Abstract
BackgroundSacubitril/valsartan is an effective treatment for heart failure with reduced ejection fraction (HFrEF) based on clinical trial data. However, little is known about its use or impact in real-world practice....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have